New clinical trial data presented at the American Heart Association Scientific Sessions in Philadelphia dominated the R&D news this week. Here are some of the highlights from the conference as well as some other bits of medtech industry news you may have missed.
The Society of Thoracic Surgeons (STS) and European Association for Cardio-Thoracic Surgery (EACTS) are recommending “caution” to patients, surgeons and interventionalists before adopting transcatheter aortic valve replacement (TAVR) as the first option for low-risk patients who need a new aortic valve.
New results from two major clinical trials suggested TAVR is a safe and effective alternative to surgery in patients at low risk for surgical complications. The safety and durability of...
The UK has issued clearer guidance to help drug and medical device sponsors demonstrate how they intend to include a diverse and relevant range of participants in their clinical trials.
Moves are at last underway for a more specific focus on orphan and pediatric devices. They are a start; but experts are calling for more to support this sector.
Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.
